Sage Journals: Discover world-class research

Retricted access

Review article

First published 2024-12

Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation

María I. Gaitán, Rocio V. Marquez, Jeremias Ayerbe [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2007-7

Improving the Decision to Pursue a Phase 3 Clinical Trial by Adjusting for Patient-Specific Factors in Evaluating Phase 2 Treatment Efficacy Data

Glenn Heller, Michael W. Kattan, Howard I. Scher

Medical Decision Making

Retricted access

Other

First published 2010-7

Design Archetypes for Phase 2 Clinical Trials in Central Nervous System Disorders

Craig H. Mallinckrodt, Michael J. Detke, William R. Prucka [...]

Therapeutic Innovation & Regulatory Science

Open access

Review article

First published 2024-12

Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS

Marcus W. Koch, Carlos Camara-Lemarroy, Eva Strijbis [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-7

Designing Phase 2 Trials Based on Program-Level Considerations

Nitin Patel, James Bolognese, Christy Chuang-Stein [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2024-9

Safety,tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers

Jennifer Schaible, Andreas Scholz, Rainer-Georg Goeldner [...]

Journal of Psychopharmacology

Open access

Article commentary

First published 2024-04-02

“Landscape of Phase 2 Trials in Alzheimer’s Disease”: Perspective on Adaptive Trials

Jeffrey Cummings

Journal of Alzheimer’s Disease

Open access

Research article

First published 2020-10

Clinical trial design in phase 2 and 3 trials for pulmonary hypertension

Sylvia Nikkho, Peter Fernandes, R. James White

Pulmonary Circulation

Retricted access

Other

First published 2003-7

Development of a Patient Recruitment Program for Phase 2 Trials in a Biotechnology Company

Stacey M. Fung, Ellen Suen, Herbert B. Lee

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2017-1

Methodological Extensions of Phase 2 Trial Designs Based on Program-Level Considerations

James Bolognese, Jaydeep Bhattacharyya, Chris Assaid [...]

Therapeutic Innovation & Regulatory Science

Search results